ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -66.5% | 18,023 | -69.2% | 0.00% | -50.0% |
| Q1 2023 | $194 | +71.7% | 58,507 | +100.5% | 0.00% | +100.0% |
| Q4 2022 | $113 | -100.0% | 29,180 | -79.5% | 0.00% | -75.0% |
| Q3 2022 | $346,000 | +276.1% | 142,471 | +206.9% | 0.00% | +300.0% |
| Q2 2022 | $92,000 | +178.8% | 46,423 | +144.7% | 0.00% | – |
| Q1 2021 | $33,000 | -26.7% | 18,968 | -18.3% | 0.00% | – |
| Q4 2020 | $45,000 | -87.0% | 23,210 | -80.4% | 0.00% | -100.0% |
| Q2 2020 | $346,000 | -4.4% | 118,200 | -6.0% | 0.00% | 0.0% |
| Q1 2020 | $362,000 | – | 125,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |